GlassScriptPhysician profile
Jennifer Meera Sim
NPI 1306340815
$2,531.41
in general payments reported to CMS, 2019-2025
16 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $123 · 2021: $909 · 2022: $444 · 2023: $325 · 2024: $309 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,175.67 | 2019-2025 | Ngenuity, Clareon |
| Bausch & Lomb Americas INC. | $216.33 | 2022-2025 | Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $152.51 | 2021 | |
| Glaukos Corporation | $127.21 | 2024 | Idose |
| Tarsus Pharmaceuticals, INC. | $126.66 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Sight Sciences, INC. | $116.58 | 2021-2022 | |
| Allergan, INC. | $99.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $98.89 | 2023-2025 | Cequa |
| Abbvie INC. | $84.81 | 2022 | |
| Mallinckrodt Hospital Products INC. | $72.31 | 2023 | Acthar |
| Oyster Point Pharma, INC. | $50.44 | 2023-2024 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $28.05 | 2019 | |
| Rayner Intraocular Lenses Limited | $21.15 | 2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Aerie Pharmaceuticals, INC. | $19.06 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.75 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Sim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.